2nd Oct 2007 16:29
GlaxoSmithKline PLC02 October 2007 Total Voting Rights and Capital as at 28 September 2007 In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc("the Company") hereby notifies the market of the following: The Company's issued share capital as at 28 September 2007 consisted of6,024,125,364 Ordinary shares of 25p each with voting rights, of which415,539,158 Ordinary shares are held in Treasury. Therefore, the total number of voting rights in the Company is 5,608,586,206.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to their interest in, the Company under the Financial ServicesAuthority's Disclosure and Transparency Rules. S M BicknellCompany Secretary 2 October 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline